Cascade Microtech Announces First Probe System with Contact Intelligence™ Technology
Sep 27, 2016 12:30 pm UTC| Business
BEAVERTON, Ore., Sept. 27, 2016 -- Cascade Microtech, a FormFactor company (NASDAQ:FORM), and a leading supplier of solutions that enable precision measurements of discrete devices and integrated circuits at the wafer...
Vector Capital Announces Successful Completion of Cash Tender Offer for Shares of Sizmek
Sep 27, 2016 12:24 pm UTC| Business
AUSTIN, Texas, Sept. 27, 2016 -- Sizmek Inc. (NASDAQ:SZMK) (the “Company” or “Sizmek”) and Vector Capital (“Vector”) today announced the successful completion of the tender offer (the “Offer”) by Solomon Merger...
Sep 27, 2016 12:19 pm UTC| Business
Dublin, Sept. 27, 2016 -- Research and Markets has announced the addition of the "Caps and Closures Market in North America 2016-2020" report to their offering. The caps and closures...
Sep 27, 2016 12:15 pm UTC| Business
Albany - New York, Sept. 27, 2016 -- A new Transparency Market Research report states that the global clinical trial management system (CTMS) market was valued at US$844 mn in 2013 and is predicted to reach US$1,848.5...
Sep 27, 2016 12:05 pm UTC| Business
-- Complete Tumor Regression Seen in 80% of Animals Treated with Triple Combination of PS-Targeting Antibody, Anti-PD-1 Therapy and Anti-Lag3 Therapy vs. 0% of Animals Receiving Double Anti-PD-1/Anti-Lag3 Treatment...
Companion Diagnostics Market worth 5.58 Billion USD by 2019; Transparency Market Research
Sep 27, 2016 12:04 pm UTC| Business
Albany – New York, Sept. 27, 2016 -- The global companion drugs market is expected to grow at 18.1% CAGR from 2013 to 2019 to reach US$5.58 bn by 2019. The market was worth US$2.80 bn in 2015. North America is projected...
RedHill Biopharma to Present at the BioNetwork West 2016 Partnering Summit
Sep 27, 2016 12:02 pm UTC| Business
TEL-AVIV, Israel, Sept. 27, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...